https://www.linkedin.com/posts/theratechnologies-inc_idweek-idweek2023-hiv-activity-7117162365468430336-T2lY?utm_source=share&utm_medium=member_ios
First presentation will be by Dr. Lindsay Fourman who has been involved in many studies/publications relating to Tesamorelin's various medical benefits.
"Dr. Fourman is an endocrinologist and Assistant Professor of Medicine at Massachusetts General Hospital and Harvard Medical School. She has a robust clinical research program geared toward elucidating mechanisms and treatment strategies for cardiometabolic disease. Her research portfolio includes studies focused on use of tesamorelin to treat nonalcoholic fatty liver disease among people with HIV as well as the investigation of long-term health outcomes among individuals with perinatal HIV exposure. Clinically, Dr. Fourman is Associate Director of MGH Lipid and Metabolism Associates, which serves as a center of excellence for the management of patients with HIV-related cardiometabolic disorders such as abdominal fat accumulation. She also directs the MGH Metabolic Disorders Conference, which melds clinical experience with scientific literature to develop best practices for various lipid and metabolic diseases."
She also will be presenting about managing central fat accumulation in PLWH together with Dr. Claudia Martorell.
"Dr. Claudia Martorell is a Board-Certified Infectious Disease Specialist and Clinical Investigator. She presently serves as the Director and Principal Investigator of The Research Institute in Springfield, Massachusetts. Clinical interests include HIV, Hepatitis C, and Hepatitis B, Sexually Transmitted Infections, HIV Prevention, Substance Use and Transgender Care.
Dr. Martorell earned her medical degree from The University of Puerto Rico School of Medicine in 1998. She completed an Internal Medicine Residency and Infectious Disease Fellowship at Baystate Medical Center. She earned a Masters of Public Health in Health Care Management from Harvard University School of Public Health, and completed a Fellowship in Health Policy and Minority Health Policy from Harvard Medical School.
She is Nationally recognized for her leadership role in HIV and HCV research, and clinical treatment in Minority Populations. She has contributed and published articles on HIV, HCV, PreP and Health Care Disparities. Dr. Martorell is also a National trainer on HIV, Hepatitis C, and HIV Prevention. Dr. Martorell has received multiple awards, including the 2007 Severo Ochoa Award for outstanding contribution to eradicating HIV/AIDS in the minority community, and was the recipient of the 2004 American Medical Association Foundation Excellence in Medicine Award."
IDWeek 2023
The third presentation is relating to viral suspension among heavily treated HIV patients.
https://idweek2023.eventscribe.net/index.asp?presTarget=2382323